$120.00
CagriSema, a dual agonist that targets both glucose regulation and appetite control, to improve weight loss in patients with and without type 2 diabetes who have overweight or obesity.
If you’ve been waiting to stock up or join the VIP program, now is the time. Once these 100 spots are taken, VIP membership will close again.